(Press-News.org) Chemotherapy activates a stress sensor in immune cells, triggering inflammation and nerve damage, which may help explain why many cancer patients experience debilitating pain as a side effect, according to a new study by Weill Cornell Medicine and Wake Forest University School of Medicine researchers.
Up to half of all patients receiving chemotherapy experience chemotherapy-induced peripheral neuropathy (CIPN), which causes tingling, numbness and pain in the hands and feet. Since there are limited options to address this condition, patients are often forced to stop their cancer treatment early. The preclinical research, published Oct. 29 in Science Translational Medicine, may lead to strategies for preventing and controlling CIPN, as well as biomarkers for identifying patients at risk.
“We uncovered a molecular mechanism that maps specifically to immune cells, not neurons,” said co-senior author Dr. Juan Cubillos-Ruiz, the William J. Ledger, M.D. Distinguished Associate Professor of Infection and Immunology in Obstetrics and Gynecology at Weill Cornell Medicine. “This provides strong evidence that chemotherapy-induced neuropathy is not just a nerve issue but an immune-mediated inflammatory process driven by cellular stress responses.”
The research was co-led by Dr. E. Alfonso Romero-Sandoval, professor of anesthesiology at Wake Forest University School of Medicine.
Piecing Together a Pain Pathway
In previous findings, Dr. Cubillos-Ruiz and his colleagues showed that a pathway called IRE1α–XBP1, a molecular “alarm system” ignited in response to cellular stress in immune cells, also promotes pain after surgery and after inflammation in mouse models.
For this study, they used a well-established mouse model that closely reflects the nerve damage experienced by cancer patients. They discovered that a commonly-used chemotherapy called paclitaxel can trigger immune cells to produce high levels of reactive oxygen species—molecules that create cellular stress. This stress flips on the IRE1α switch, which pushes immune cells into a highly inflammatory state.
These hyperactive immune cells then travel to the dorsal root ganglia—the sensory nerve clusters that connect the limbs to the spinal cord—and release inflammatory molecules that irritate and damage nerves. This chain reaction produces the hallmark symptoms of CIPN: pain, cold sensitivity and nerve fiber loss.
Silencing IRE1α in immune cells using genetic techniques prevented this inflammatory surge and reduced CIPN-related behaviors in mice. The research team also used a drug that selectively inhibits IRE1α and is already in phase 1 clinical trials as a cancer treatment. Mice receiving chemotherapy together with the IRE1α inhibitor displayed reduced pain behaviors typically seen after paclitaxel treatment, and their nerves stayed healthier.
“Our findings suggest that targeting IRE1α pharmacologically could mitigate neuropathy induced by taxanes, helping patients continue with their chemotherapy without the negative side effects of nerve damage,” said Dr. Cubillos-Ruiz, who is also co-leader of the Cancer Biology Program at the Sandra and Edward Meyer Cancer Center at Weill Cornell.
Since IRE1α inhibitors are already being evaluated in patients with advanced solid tumors—where abnormal activation of this pathway is known to fuel cancer progression and therapy resistance—the new results raise the possibility that the same drugs could also protect patients from chemotherapy-induced nerve damage. According to Dr. Cubillos-Ruiz, such a dual benefit “could meaningfully improve both the effectiveness of cancer treatment and patients’ quality of life.”
A Promising Biomarker for Patients
To see how their preclinical findings could translate to patients, the researchers conducted a small pilot study with women receiving paclitaxel for gynecologic cancers. They drew blood before and during each chemotherapy cycle and found that patients who later developed severe CIPN had higher activation of the IRE1α–XBP1 pathway in their circulating immune cells, even before symptoms appeared.
This means a blood test might eventually help identify individuals at highest risk of neuropathy, allowing for preventive measures—potentially including IRE1α inhibitors—before nerve damage occurs.
Many Weill Cornell Medicine physicians and scientists maintain relationships and collaborate with external organizations to foster scientific innovation and provide expert guidance. The institution makes these disclosures public to ensure transparency. For this information, please see the profile for Dr. Juan Cubillos-Ruiz.
This research was supported by the National Cancer Institute and the National Institute of Neurological Disorders and Stroke of the National Institutes of Health, as well as the U.S. Department of Defense.
END
Scientists identify a molecular switch to a painful side effect of chemotherapy
2025-11-21
ELSE PRESS RELEASES FROM THIS DATE:
When the air gets dry, cockroaches cuddle: Binghamton University study reveals survival strategy
2025-11-21
When conditions get too dry, Madagascar hissing cockroaches like to "cuddle". Under certain conditions, the large insects gather in groups, with many participants in physical contact with one another. According to recent research from Binghamton University’s Biological Sciences program, this strategy may prevent the cockroaches from drying out.
The new study, “Plastic Behavioral Responses to Ambient Relative Humidity Influence Aggregation in a Large Gregarious Insect”, recently appeared in the journal Ethology, and was co-authored by Binghamton University Assistant ...
Study finds unsustainable water use across the Rio Grande
2025-11-21
Across the Rio Grande–Bravo basin, which runs from Colorado to Mexico, water stress has been building for years.
Reservoirs that once relied on steady snowmelt are now noticeably lower. Aquifers that supported farming communities for generations continue to decline, dropping faster than they can recharge. In some stretches, the river, which runs nearly 3,000 kilometers, disappears into dry sand before reaching its endpoint.
Despite this growing strain, a full, basin-wide picture of how the river’s water is used and how much is being lost didn’t exist. People could see the symptoms, but ...
UBCO engineers create new device to improve indoor air quality
2025-11-21
With winter approaching and people spending more time indoors, the quality of the air they breathe becomes increasingly important. Especially during cold and flu season.
Researchers at UBC Okanagan are exploring an air-cleaning device that can remove airborne pathogens, offering a powerful new tool for reducing the spread of respiratory diseases in enclosed spaces.
The traditional approach to alleviating transmission of infectious diseases involves improving a building’s ventilation system to regulate large-scale airflow, explains study co-author Dr. Sunny Li, professor in the School of Engineering.
Personalized ventilation systems ...
Arginine supplementation curbs Alzheimer’s disease pathology in animal models
2025-11-21
Alzheimer’s disease (AD), a progressive neurodegenerative disorder, is one of the leading causes of dementia worldwide, and currently has no definitive cure. Although antibody-based therapies that target amyloid β (Aβ) have recently been developed, their clinical effectiveness remains limited. These treatments can be costly and cause immune-related side effects, highlighting the need for safer, affordable, and widely accessible approaches that can slow the progression of AD.
In a new study, made available online on October 30, 2025, in Neurochemistry International, researchers from Kindai ...
Stick and Glue! Researchers at IOCB Prague introduce a new biomolecule-labeling method for more precise observation of cellular processes
2025-11-21
A team of researchers at IOCB Prague headed by Dr. Tomáš Slanina has developed a new method for labeling molecules with fluorescent dyes that surpasses existing approaches in both precision and stability. The new fluorescent label remains covalently bonded to its target molecule and does not fall apart even under demanding conditions inside living cells. This allows scientists to track labeled molecules over long periods with high reliability – an advantage for research in biology, chemistry, and medicine. The study was published in Angewandte Chemie International Edition. ...
Brain “stars” hold the power to preserve cognitive function in model of Alzheimer’s disease
2025-11-21
Researchers at Baylor College of Medicine have discovered a natural mechanism that clears existing amyloid plaques in the brains of mouse models of Alzheimer’s disease and preserves cognitive function. The mechanism involves recruiting brain cells known as astrocytes, star shaped cells in the brain, to remove the toxic amyloid plaques that build up in many Alzheimer’s disease brains. Increasing the production of Sox9, a key protein that regulates astrocyte functions during aging, triggered ...
New CAR T strategy targets most common form of heart disease
2025-11-21
PHILADELPHIA – A pioneering preclinical study has shown that CAR T cell therapy—a personalized form of immunotherapy used in cancer treatment—could be a highly effective tool against atherosclerosis, the condition where a build-up of plaque in the arteries reduces blood flow, leading to heart attacks and strokes. In tests in mice, the experimental CAR T cells blocked inflammation in arteries, preventing more than two-thirds of the plaque buildup seen in untreated controls. The research, led by scientists in the Perelman School of Medicine at the University of Pennsylvania, was published today in Circulation.
“Our ...
Why some volcanoes don’t explode
2025-11-21
The explosiveness of a volcanic eruption depends on how many gas bubbles form in the magma – and when. Until now, it was thought that gas bubbles were formed primarily when the ambient pressure dropped while the magma was rising. Gases that were dissolved in the magma in lower strata – due to the higher pressure – escape when the pressure drops and form bubbles. The more bubbles there are in the magma, the lighter it becomes and the faster it rises. This can cause the magma to tear apart, leading to an explosive eruption.
This process can be likened to a bottle of champagne: while the bottle is closed and therefore pressurised, the carbon dioxide remains ...
New stem cell medium creates contracting canine heart muscle cells
2025-11-21
In research, induced pluripotent stem (iPS) cells are derived from skin, urine, or blood samples and developed into other cells, like heart tissue, that researchers want to study. Because of the similarities between certain dog and human diseases, canine iPS cells have potential uses in regenerative medicine and drug discovery.
Research on iPS cells is challenging because the cells are extremely sensitive to culture conditions. Before they are developed into other cells, iPS cells are in an undifferentiated state. At this stage, the cells are grown in a culture medium that provides the essential nutrients, growth factors, and signaling molecules that they ...
Deep learning-assisted organogel pressure sensor for alphabet recognition and bio-mechanical motion monitoring
2025-11-21
As wearable electronics migrate toward real-time health monitoring and seamless human–machine interfaces, conventional hydrogels freeze, dry out and fracture under daily conditions. Now, a multidisciplinary team led by Prof. Sang-Jae Kim (Jeju National University) has unveiled a CoN-CNT/PVA/GLE organogel sensor that marries sub-zero toughness with AI-grade pattern recognition. The device delivers 5.75 kPa-1 sensitivity across 0–20 kPa, heals in 0.24 s, and classifies handwritten English letters at 98 % accuracy—offering a robust, bio-compatible platform for next-generation soft robotics ...